Purpose: Bikunin is a Kunitz-type protease inhibitor found in serum and uri
ne. It has been implicated in urinary stone formation. This study was desig
ned to investigate the role of urinary bikunin in stone formation.
Materials and Methods: Urinary concentrations of bikunin were measured in 1
8 male formers of urinary stones 28 to 74 years old and in 77 healthy contr
ols, including 39 males and 38 females, without urological abnormality. A s
ensitive competitive solid phase enzyme immunoassay was established for uri
nary bikunin. Bikunin was also qualitatively assessed by Western blot analy
sis.
Results: The mean urinary bikunin-to-creatinine ratio plus or minus standar
d deviation in stone formers was significantly elevated compared with that
in healthy male and female controls (52.3 +/- 46.0 mug./mg. creatinine vers
us 28.0 +/- 30.4 and 26.5 +/- 21.7, p = 0.005 and 0.006, respectively). By
Western blot analysis all urine samples contained authentic 40 kDa. bikunin
species. However, a significantly higher proportion of patients was found
to have aberrant 25 kDa. bikunin species compared with controls (10 of 18 o
r 55.6% versus 15 of 77 or 19.5%, p = 0.002). Experiments on de-glycosylati
on with chondroitinase ABC, amino acid sequencing of the aberrant bikunin s
pecies and calcium oxalate crystal growth inhibition assay demonstrated tha
t the 25 kDa. bikunin fragment was identical to de-glycosylated bikunin and
less inhibitory on calcium oxalate crystal growth.
Conclusions: If urinary bikunin is important in the pathogenesis of urolith
iasis, its effect is probably attributable to the concentration and degree
of glycosylation.